NOVEL PHARMA INC has a total of 12 patent applications. Its first patent ever was published in 2018. It filed its patents most often in Australia, Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals and biotechnology are BIOSINTETICA FARMACEUTICA LTDA, WONG BING LOU and ZENGEN INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 2 | |
#2 | Canada | 2 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | Republic of Korea | 2 | |
#5 | United States | 2 | |
#6 | Russian Federation | 1 | |
#7 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Jin Dong Kyu | 12 |
Publication | Filing date | Title |
---|---|---|
CA3102364A1 | Long-acting fatty acid-conjugated gnrh derivatives and pharmaceutical compositions containing same | |
KR102100771B1 | A long-acting form of gnrh analogue conjugated with fatty acid and a pharmaceutical composition comprising thereof | |
RU2746566C2 | Palmitic acid conjugated prolonged gnrh derivative and pharmaceutical composition containing it |